Pliant Therapeutics, Inc. announced that Keith Cummings, M.D., MBA, has joined the company as chief financial officer and Eduard Gorina, M.D., has joined as vice president, clinical development. Dr. Cummings has 15 years of experience in healthcare and financial services. He joins Pliant from Citigroup Global Markets where he served as a director in the Investment Banking Healthcare Group focusing on small- and mid-cap life sciences companies.

Dr. Gorina joins the clinical development team under the leadership of Chief Medical Officer Eric Lefebvre and is responsible for overseeing the execution of Pliant's trials in multiple fibrotic diseases. Previously, he was executive director of clinical development at FibroGen, where he managed clinical programs for fibrotic diseases including idiopathic pulmonary fibrosis (IPF) and Duchenne muscular dystrophy.